Nebivolol description: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Redirected page to Nebivolol#Pharmacology)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Nebivolol#Pharmacology]]
{{Nebivolol}}
{{CMG}}; {{AE}} {{SS}}
 
==Description==
The chemical name for the active ingredient in BYSTOLIC (nebivolol) tablets is (1RS,1'RS)-1,1'-[(2RS,2'SR)-bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]- 2,2'-iminodiethanol hydrochloride. Nebivolol is a racemate composed of d-Nebivolol and l-Nebivolol with the stereochemical designations of [SRRR]-nebivolol and [RSSS]-nebivolol, respectively. Nebivolol's molecular formula is (C22H25F2NO4•HCl) with the following structural formula:
{|
|-
|[[File:Nebivolol03.jpg|thumb|1200px]]
|-
|}
 
{|
|-
|[[File:Nebivolol02.jpg|thumb|600px]]
|-
|}
Nebivolol hydrochloride is a white to almost white powder that is soluble in methanol, dimethylsulfoxide, and N,N-dimethylformamide, sparingly soluble in ethanol, propylene glycol, and polyethylene glycol, and very slightly soluble in hexane, dichloromethane, and methylbenzene.
 
BYSTOLIC as tablets for oral administration contains nebivolol hydrochloride equivalent to 2.5, 5, 10, and 20 mg of nebivolol base. In addition, BYSTOLIC contains the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, D&C Red #27 Lake, FD&C Blue #2 Lake, FD&C Yellow #6 Lake, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, pregelatinized starch, polysorbate 80, and sodium lauryl sulfate.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = BYSTOLIC (NEBIVOLOL HYDROCHLORIDE) TABLET [FOREST LABORATORIES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b8ad213-1dc8-454e-a524-075685c0e1a8 | publisher =  | date =  | accessdate = 4 February 2014 }}</ref>
 
 
 
 
 
==References==
 
{{Reflist|2}}
 
[[Category:Beta blockers]]
 
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 01:29, 22 July 2014